SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-029160
Filing Date
2019-12-13
Accepted
2019-12-13 16:17:25
Documents
1
Period of Report
2019-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5698
  Complete submission text file 0000899243-19-029160.txt   7173
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Issuer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK NJ 07601
Business Address
Polverino Anthony J. (Reporting) CIK: 0001729957 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38068 | Film No.: 191284793